Although these results indicate that CBP/p300 has an essential role in the mechanism of CRC metastasis, the relationship between CBP/p300 and some clinical features, such as tumor-node-metastasis (TNM) stage, survival rate and metastasis rate, is inconsistent[23–25]. This evidence concerns the gene EP300 and neoplasm.